P A Seymour

1.7k total citations
14 papers, 1.4k citations indexed

About

P A Seymour is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, P A Seymour has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in P A Seymour's work include Stress Responses and Cortisol (2 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Tryptophan and brain disorders (2 papers). P A Seymour is often cited by papers focused on Stress Responses and Cortisol (2 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Tryptophan and brain disorders (2 papers). P A Seymour collaborates with scholars based in United States, United Kingdom and Canada. P A Seymour's co-authors include Anne W. Schmidt, David W. Schulz, Thomas Seeger, Victor Guanowsky, Lorraine A. Lebel, F. David Tingley, Michael L. Corman, Alan H. Ganong, Harry Howard and Samantha L. McLean and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Infection and Immunity.

In The Last Decade

P A Seymour

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P A Seymour United States 10 570 495 346 267 234 14 1.4k
Lawrence W. Fitzgerald United States 23 649 1.1× 944 1.9× 334 1.0× 70 0.3× 171 0.7× 42 2.0k
Y. Claustre France 22 682 1.2× 1.1k 2.2× 141 0.4× 322 1.2× 77 0.3× 32 1.7k
Masahiko Tatsumi Japan 20 663 1.2× 827 1.7× 96 0.3× 419 1.6× 229 1.0× 33 2.0k
Ágnes Rimanóczy Hungary 25 386 0.7× 460 0.9× 249 0.7× 250 0.9× 162 0.7× 59 1.5k
James Heym United States 26 864 1.5× 1.5k 3.0× 326 0.9× 110 0.4× 124 0.5× 43 2.4k
Minoru Takebayashi Japan 25 908 1.6× 893 1.8× 310 0.9× 315 1.2× 423 1.8× 108 2.1k
Dorota Maciąg Poland 16 222 0.4× 434 0.9× 307 0.9× 98 0.4× 322 1.4× 32 1.3k
Susan K. Hemrick-Luecke United States 22 442 0.8× 876 1.8× 118 0.3× 222 0.8× 83 0.4× 70 1.6k
Johann Meunier France 24 866 1.5× 541 1.1× 227 0.7× 65 0.2× 318 1.4× 39 1.9k
M. Julia García‐Fuster Spain 24 418 0.7× 845 1.7× 220 0.6× 149 0.6× 205 0.9× 87 1.6k

Countries citing papers authored by P A Seymour

Since Specialization
Citations

This map shows the geographic impact of P A Seymour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P A Seymour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P A Seymour more than expected).

Fields of papers citing papers by P A Seymour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P A Seymour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P A Seymour. The network helps show where P A Seymour may publish in the future.

Co-authorship network of co-authors of P A Seymour

This figure shows the co-authorship network connecting the top 25 collaborators of P A Seymour. A scholar is included among the top collaborators of P A Seymour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P A Seymour. P A Seymour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Seymour, P A, et al.. (2023). A Brief Comprehensive Review of the Interactions Between Attention-Deficit/Hyperactivity Disorder and Internet Gaming Disorder. International Journal of Mental Health and Addiction. 23(3). 2046–2051. 3 indexed citations
2.
Dawson, Neil, Masaki Kurihara, David M. Thomson, et al.. (2015). Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1. Translational Psychiatry. 5(5). e569–e569. 35 indexed citations
3.
Kozak, Rouba, Brian Campbell, Christine A. Strick, et al.. (2014). Reduction of Brain Kynurenic Acid Improves Cognitive Function. Journal of Neuroscience. 34(32). 10592–10602. 137 indexed citations
4.
Schmidt, C J, Douglas S. Chapin, Michael L. Corman, et al.. (2008). Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia. Journal of Pharmacology and Experimental Therapeutics. 325(2). 681–690. 238 indexed citations
5.
Chan, Alan, et al.. (2004). Dose-specific effects of scopolamine on canine cognition: Impairment of visuospatial memory, but not visuospatial discrimination. Psychopharmacology. 175(1). 92–8. 30 indexed citations
6.
WELCH, W. M., Frank E. Ewing, Frank S. Menniti, et al.. (2001). Atropisomeric quinazolin-4-one derivatives are potent noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 11(2). 177–181. 107 indexed citations
7.
Schulz, David W., Robert S. Mansbach, Jeffrey Sprouse, et al.. (1996). CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.. Proceedings of the National Academy of Sciences. 93(19). 10477–10482. 308 indexed citations
8.
Seeger, Thomas, P A Seymour, Anne W. Schmidt, et al.. (1995). Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.. Journal of Pharmacology and Experimental Therapeutics. 275(1). 101–113. 271 indexed citations
9.
McLean, Stafford, Alan H. Ganong, P A Seymour, et al.. (1993). Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.. Journal of Pharmacology and Experimental Therapeutics. 267(1). 472–479. 205 indexed citations
10.
McLean, Stafford, Alan H. Ganong, P A Seymour, et al.. (1992). Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin NK1 receptor. Regulatory Peptides. 37. S120–S120. 40 indexed citations
11.
Lowe, John, Thomas Seeger, A. Nagel, et al.. (1991). ChemInform Abstract: 1‐Naphthylpiperazine Derivatives as Potential Atypical Antipsychotic Agents.. ChemInform. 22(46). 1 indexed citations
13.
Seymour, P A, E. Edward Mena, Samantha L. McLean, & James Heym. (1990). Pharmacology of the serotonergic anxiolytic tandospirone (SM-3997).. PubMed. 361. 453–60. 4 indexed citations
14.
Otterness, Ivan G., et al.. (1989). Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation. Infection and Immunity. 57(9). 2742–2750. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026